Dr Hilarion Bibicoff, DO | |
3537 W Front St Ste E, Traverse City, MI 49684-7943 | |
(231) 935-8930 | |
(231) 935-8811 |
Full Name | Dr Hilarion Bibicoff |
---|---|
Gender | Male |
Speciality | Family Practice |
Experience | 11 Years |
Location | 3537 W Front St Ste E, Traverse City, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114367703 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 5101020506 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Munson Medical Center | Traverse city, MI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
West Front Primary Care Pllc | 4183514706 | 16 |
News Archive
A researcher from Johns Hopkins Medicine helped lead colleagues from across the country in a government-sponsored study by the Diabetic Retinopathy Clinical Research Network to discover that three drugs - Eylea, Avastin and Lucentis - used to treat diabetic macular edema are all effective. They also discovered that Eylea outperformed the other two drugs when vision loss was moderate to severe.
An advanced tumor is a complex ecosystem. Though derived from a single cell, it evolves as it grows until it contains several subspecies of cells that vary dramatically in their genetic traits and behaviors.
Poor physical fitness and sedentary behaviour are linked to increased pain conditions in children as young as 6-8 years old, according to the Physical Activity and Nutrition in Children Study ongoing at the University of Eastern Finland. The findings were published in the Journal of Pain.
Pharmalink AB, today announced that it has closed its agreement with Grifols SA for the acquisition of Pharmalink's Xepol(R) programme for the treatment of post-polio syndrome (PPS). The parties had previously announced reaching an agreement whereby Grifols would acquire all know-how and global intellectual property rights related to the use of human immunoglobulin for the treatment of (PPS) - the concept at the heart of the Xepol programme.
› Verified 4 days ago
Entity Name | Munson Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083761860 PECOS PAC ID: 3072426287 Enrollment ID: O20040108000904 |
News Archive
A researcher from Johns Hopkins Medicine helped lead colleagues from across the country in a government-sponsored study by the Diabetic Retinopathy Clinical Research Network to discover that three drugs - Eylea, Avastin and Lucentis - used to treat diabetic macular edema are all effective. They also discovered that Eylea outperformed the other two drugs when vision loss was moderate to severe.
An advanced tumor is a complex ecosystem. Though derived from a single cell, it evolves as it grows until it contains several subspecies of cells that vary dramatically in their genetic traits and behaviors.
Poor physical fitness and sedentary behaviour are linked to increased pain conditions in children as young as 6-8 years old, according to the Physical Activity and Nutrition in Children Study ongoing at the University of Eastern Finland. The findings were published in the Journal of Pain.
Pharmalink AB, today announced that it has closed its agreement with Grifols SA for the acquisition of Pharmalink's Xepol(R) programme for the treatment of post-polio syndrome (PPS). The parties had previously announced reaching an agreement whereby Grifols would acquire all know-how and global intellectual property rights related to the use of human immunoglobulin for the treatment of (PPS) - the concept at the heart of the Xepol programme.
› Verified 4 days ago
Entity Name | West Front Primary Care Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1851490296 PECOS PAC ID: 4183514706 Enrollment ID: O20040317001391 |
News Archive
A researcher from Johns Hopkins Medicine helped lead colleagues from across the country in a government-sponsored study by the Diabetic Retinopathy Clinical Research Network to discover that three drugs - Eylea, Avastin and Lucentis - used to treat diabetic macular edema are all effective. They also discovered that Eylea outperformed the other two drugs when vision loss was moderate to severe.
An advanced tumor is a complex ecosystem. Though derived from a single cell, it evolves as it grows until it contains several subspecies of cells that vary dramatically in their genetic traits and behaviors.
Poor physical fitness and sedentary behaviour are linked to increased pain conditions in children as young as 6-8 years old, according to the Physical Activity and Nutrition in Children Study ongoing at the University of Eastern Finland. The findings were published in the Journal of Pain.
Pharmalink AB, today announced that it has closed its agreement with Grifols SA for the acquisition of Pharmalink's Xepol(R) programme for the treatment of post-polio syndrome (PPS). The parties had previously announced reaching an agreement whereby Grifols would acquire all know-how and global intellectual property rights related to the use of human immunoglobulin for the treatment of (PPS) - the concept at the heart of the Xepol programme.
› Verified 4 days ago
Entity Name | Novello Infusion Plc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417681305 PECOS PAC ID: 6204202245 Enrollment ID: O20221017002636 |
News Archive
A researcher from Johns Hopkins Medicine helped lead colleagues from across the country in a government-sponsored study by the Diabetic Retinopathy Clinical Research Network to discover that three drugs - Eylea, Avastin and Lucentis - used to treat diabetic macular edema are all effective. They also discovered that Eylea outperformed the other two drugs when vision loss was moderate to severe.
An advanced tumor is a complex ecosystem. Though derived from a single cell, it evolves as it grows until it contains several subspecies of cells that vary dramatically in their genetic traits and behaviors.
Poor physical fitness and sedentary behaviour are linked to increased pain conditions in children as young as 6-8 years old, according to the Physical Activity and Nutrition in Children Study ongoing at the University of Eastern Finland. The findings were published in the Journal of Pain.
Pharmalink AB, today announced that it has closed its agreement with Grifols SA for the acquisition of Pharmalink's Xepol(R) programme for the treatment of post-polio syndrome (PPS). The parties had previously announced reaching an agreement whereby Grifols would acquire all know-how and global intellectual property rights related to the use of human immunoglobulin for the treatment of (PPS) - the concept at the heart of the Xepol programme.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Hilarion Bibicoff, DO 3537 W Front St Ste E, Traverse City, MI 49684-7943 Ph: (231) 935-8930 | Dr Hilarion Bibicoff, DO 3537 W Front St Ste E, Traverse City, MI 49684-7943 Ph: (231) 935-8930 |
News Archive
A researcher from Johns Hopkins Medicine helped lead colleagues from across the country in a government-sponsored study by the Diabetic Retinopathy Clinical Research Network to discover that three drugs - Eylea, Avastin and Lucentis - used to treat diabetic macular edema are all effective. They also discovered that Eylea outperformed the other two drugs when vision loss was moderate to severe.
An advanced tumor is a complex ecosystem. Though derived from a single cell, it evolves as it grows until it contains several subspecies of cells that vary dramatically in their genetic traits and behaviors.
Poor physical fitness and sedentary behaviour are linked to increased pain conditions in children as young as 6-8 years old, according to the Physical Activity and Nutrition in Children Study ongoing at the University of Eastern Finland. The findings were published in the Journal of Pain.
Pharmalink AB, today announced that it has closed its agreement with Grifols SA for the acquisition of Pharmalink's Xepol(R) programme for the treatment of post-polio syndrome (PPS). The parties had previously announced reaching an agreement whereby Grifols would acquire all know-how and global intellectual property rights related to the use of human immunoglobulin for the treatment of (PPS) - the concept at the heart of the Xepol programme.
› Verified 4 days ago
Satya Pillay, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 Medical Campus Dr, Traverse City, MI 49684 Phone: 231-935-8000 Fax: 231-935-8099 | |
Samantha K Windle, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 Medical Campus Dr, Traverse City, MI 49684 Phone: 231-935-8000 Fax: 231-935-8099 | |
Dr. Donald James Aiken, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 16544 Wrightwood Terrace Dr, Traverse City, MI 49686 Phone: 231-223-7465 | |
Kaitlyn Lee Kilpatrick, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1400 Medical Campus Dr, Traverse City, MI 49684 Phone: 231-935-8000 Fax: 231-935-8099 | |
Ferris Alkazir, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 550 Munson Ave, Traverse City, MI 49686 Phone: 231-935-6600 Fax: 231-935-9290 | |
David J Wilcox, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 906 Business Park Dr, Traverse City, MI 49686 Phone: 800-968-6866 | |
Mark A Jackson, MD Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1000 Pavilions Circle, Mark A Jackson Md Plc, Traverse City, MI 49684 Phone: 231-935-0913 Fax: 231-935-0984 |